Search

everythinglearnresearchcommunity

for

Search:↓

The A allele of the C2 gene increases the risk of lupus, while the G allele may protect against it.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Understanding SARS-CoV-2's spread and immune response is key to developing treatments and vaccines, but preventive measures remain important.

The complement system might be involved in the development of alopecia areata and could lead to new treatments.

A 13-year-old girl was diagnosed with juvenile lupus, showing only hair loss as a symptom.

A woman with lupus had blood cell destruction, treated successfully with medication.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Rash in SLE patients indicates more severe disease.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Recognizing LET and AITD can help diagnose SLE early for better treatment.

SLE in ageing patients is less severe and needs careful treatment to avoid excess.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Scientists found genes linked to the growth of high-quality brush hair in Chinese Haimen goats.

Key proteins and pathways regulate yak hair growth, with lipid metabolism aiding adaptation to high altitudes.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

BIVV009 is a safe treatment for bullous pemphigoid that reduces C3 deposition without harmful side effects.

Stress hormones like cortisol may trigger psoriasis flare-ups.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Alopecia areata may be caused by the immune system attacking hair follicles.

The study suggests that complement activation, not immunoglobulins, may be important in erythema nodosum leprosum.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

A patient with Rhupus was diagnosed with Rowell syndrome and treated with various medications.

Patients with Systemic Sclerosis have much higher levels of GDF-15, which could help predict organ involvement and guide treatment.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

It's unclear if COVID-19 vaccination causes SLE; more research is needed.

The new delivery system could improve pain and inflammation relief in gout.

Current SLE classifications need refinement, and the complement system is a key therapeutic target.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

Transplanted hair follicles can change and adapt to new areas of the body, with the immune system possibly playing a role in this adjustment.

A gene in Sebekia benihana, CYP-sb21, is needed for a specific reaction on the drug Cyclosporine A, which could be important for hair growth without affecting the immune system.